Additional information
Active substance | Silodosin |
---|---|
Formula | C25H32F3N3O4 |
Side effects | Dizziness, orthostatic hypotension, retrograde ejaculation, headache, diarrhea |
Effects | Improves urinary flow and symptoms associated with benign prostatic hyperplasia (BPH) |
Dosage (sports) | Not applicable |
Dosage (medical) | Typically 8 mg once daily |
Half-life | Approximately 13 hours |
Main action | Reduces smooth muscle contraction in the prostate and urethra |
Substance class | Alpha-1 adrenergic receptor antagonist |
Chemical name | 1-(3-Hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide |
Storage conditions | Store at room temperature away from moisture and heat |
Trade name | Rapaflo, Silodyx |
Blood pressure | May cause a decrease in blood pressure |
Also known as | KMD-3213 |
Lab Test | Not specific |
Hepatotoxicity | Low |
Water Retention | Minimal to none |
Use in sports | None |
Manufacturer | Recordati |
Packing | 30 tabs (4mg/tab) |
Reviews
There are no reviews yet.